Cutting Edge Urology

T his PDF belongs to matthew.hooson@springer.co INTERVENTIONAL ULTRASOUND: TRANSPERINEAL AND TRANSRECTAL PROSTATIC BIOPSY • 31  58. Katz DJ, Pinochet R, Richards KA, Godoy G, Udo K, Nogueira L, Cronin AM, Fine SW, Scardino PT, Coleman JA (2014) Comparison of transperineal mapping biopsy results with whole-mount radical prostatectomy pathology in patients with localized prostate cancer. Prostate Cancer 2014:781438. doi:10.1155/2014/781438, Epub 2014 May 11. 59. Ouzzane A, Renard Penna R, Marliere F, Mozer P, Olivier J, Barkatz J, Puech P, Villers A (2015) Magnetic resonance imaging targeted biopsy improves selection of patients considered for active surveillance for clinically low risk prostate cancer based on systematic biopsies. J Urol 194:350–356. 60. Kamrava M, Kishan AU, Margolis DJ, Huang J, Dorey F, Lieu P, Kupelian PA, Marks LS (2015) Multiparametric magnetic resonance imaging for prostate cancer improves Gleason score assessment in favorable risk prostate cancer. Pract Radiat Oncol. pii: S18798500 (15)00154X. doi: 10.1016/j.prro.2015.04.006. [Epub ahead of print]. 61. Radtke JP, Kuru TH, Boxler S, Alt CD, Popeneciu IV, Huettenbrink C, Klein T, Steinemann S, Bergstraesser C, Roethke M, Roth W, Schlemmer HP, Hohenfellner M, Hadaschik BA (2015) Comparative analysis of transperineal template saturation prostate biopsy versus magnetic resonance imaging targeted biopsy with magnetic resonance imaging-ultrasound fusion guidance. J Urol 193:87–94. 62. Kuru TH, Roethke MC, Seidenader J, Simpfendörfer T, Boxler S, Alammar K, Rieker P, Popeneciu VI, Roth W, Pahernik S, Schlemmer HP, Hohenfellner M, Hadaschik BA (2013) Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer. J Urol 190:1380–1386. 63. Fascelli M, George AK, Frye T, Turkbey B, Choyke PL, Pinto PA (2015) The role of MRI in active surveillance for prostate cancer. Curr Urol Rep 16:42. 64. Kim TH, Jeong JY, Lee SW, Kim CK, Park BK, Sung HH, Jeon HG, Jeong BC, Seo SI, Lee HM, Choi HY, Jeon SS (2015) Diffusion weighted magnetic resonance imaging for prediction of insignificant prostate cancer in potential candidates for active surveillance. Eur Radiol 25:1786–1792. 65. Guo R, Cai L, Fan Y, Jin J, Zhou L, Zhang K (2015) Magnetic resonance imaging on disease reclassification among active surveillance candidates with lowrisk prostate cancer; a diagno tic meta-analysis. Prostate Cancer Prostatic Dis 18:221–228. 66. Pepe P, Dibenedetto G, Garufi A, Priolo G, Pennisi M (2015) Multiparametric pelvic MRI accuracy in diagnosing clinically significant prostate cancer in the re-evaluation of biopsy microfocal tumor. Anticancer Res 35:395–399. 67. Volkin D, Turkbey B, Hoang AN, Rais-Bahrami S, Yerram N, Walton-Diaz A, Nix JW, Wood BJ, Choyke PL, Pinto PA (2014) Multiparametric MRI and subsequent MR/ultrasound fusion-guided biopsy increase the detection of anteriorly located prostate cancers. BJU Int 114(6b):E43–E49. doi:10.1111/bju.12670. 68. Pepe P, Aragona F (2013) Morbidity following transperineal prostate biopsy in 3,000 patients submitted to 12 VS 18 VS more than 24 needle cores. Urology 81:1142–1146. 69. Grummet JP, Weerakoon M, Huang S, Lawrentschuk N, Frydenberg M, Moon DA, O’Reilly M, Murphy D (2014) Sepsis and ‘superbugs’: should we favour the transperineal over the transrectal approach for prostate biopsy? BJU Int 114:384–388. 70. Minamida S, Satoh T, Tabata K, Kimura M, Tsumura H, Kurosaka S, Matsumoto K, Fujita T, Iwamura M, Baba S (2011) Prevalence of fluoroquinolone-resistant Escherichia coli before and incidence of acute bacterial prostatitis after prostate biopsy. Urology 78:1235–1239. 71. Pinkhasov GI, Lin YK, Palmerola R, Smith P, Mahon F, Kaag MG, Dagen JE, Harpster LE, Reese CT, Raman JD et al (2012) Complications following prostate needle biopsy requiring hospital admission or emergency department visits – experience from 1000 consecutive cases. BJU Int 110:369–374. 72. Ehdaie B, Vertosick E, Spaliviero M, Giallo-Uvino A, Taur Y, O’Sullivan M, Livingston J, Sogani P, Eastham J, Scardino P, Touijer K (2014) The impact of repeat biopsies on infectious complications in men with prostate cancer on active surveillance. J Urol 191:660–664. 73. Chang DT , Challacombe B, Lawre ntschuk N (2013) Transperineal biopsy of the prostate – is this the future? Nat Rev Urol 10: 690–702. 74. Rosario DJ, Lane JA, Metcalf e C, Donovan JL, Doble A, Goodwin L, Davis M, Catto JW, Avery K, Neal DE, Hamdy FC (2012) Short termo utcom es of prostate biopsy inmen tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study. BMJ 344:d7894. doi:10.1136/bmj.d7894. 75. Yuan LR, Zhang CG, Lu LX, Ruan L, Lan JH, Feng SQ, Luo JD (2014) Comparison of ultrasound-guided transrectal and transperineal prostate biopsies in clinical application. Zhonghua Nan Ke Xue 20:1004–1007. 76. Merrick GS, Taubenslag W, Andreini H, Brammer S, Butler WM, Adamovich E, Allen Z, Anderson R, Wallner KE (2008) The morbidity of transperineal template-guided prostate mapping biopsy. BJU Int 101:1524–1529. 77. Nam RK, Saskin R, Lee Y, Liu Y, Law C, Klotz LH, Loblaw DA, Trachtenberg J, Stanimirovic A, Simor AE, Seth A, Urbach DR, Narod SA (2010) Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. J Urol 183:963–968. Cutting EDGE_Urology(SUN)_final.indd 31 27-Mar-18 10:00:30 AM